Generics 15

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Vinorelbine manufacturers

15 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

15 products found

vinorelbine

Solution for injection 10mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
Manufacturer #557
This organization is a multinational pharmaceutical company dedicated to providing affordable healthcare globally. They offer over 1,500 products across various therapeutic areas including HIV/AIDS, making significant contributions to accessibility in emerging markets like India, South Africa, and the U.S. Their product portfolio encompasses over 50 dosage forms, ranging from prescription medications and OTC drugs to potentially medical devices and supplements. They prioritize GMP certifications and hold patents for key products. Their commitment to affordability and inclusiveness has earned them recognition as a leader in global health initiatives.

Manufacturer usually replies in 6 days

vinorelbine

Injection 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #22283
This company is a leading manufacturer of anti-cancer medications, specializing in a wide range of oncology drugs including those for solid tumors, hematology, and supportive care. They boast a portfolio of over 100 products with a focus on cost-effectiveness through in-house API development and manufacturing. The company's commitment to innovation is evident in their New Drug Delivery System (NDDS) formulations which aim to improve patient compliance and reduce medication waste. Their strong R&D pipeline promises further advancements in the oncology field. They hold WHO-GMP certifications for their API plant, enabling both domestic and international market reach. Key therapy areas include AML, Renal Cell Carcinoma, Gastro-Intestinal tumors, Pancreatic Neuroendocrine Tumors, Thyroid cancer, and Prostate cancer.

Manufacturer usually replies in 5 days

vinorelbine

Injection 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20510
This company specializes in oncology medications, with a focus on providing high-quality products that meet international pharmaceutical standards. They operate dedicated oncology units certified under both EU GMP and WHO GMP guidelines to ensure consistent quality across their range of products. Their key therapy areas likely revolve around cancer treatment, and they offer various dosage forms to address diverse patient needs. The company is committed to regulatory compliance, working closely with local and international bodies to maintain approvals for all their medications.

Manufacturer usually replies in 2 days

Want to see all 15 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

What is the Vinorelbine drug?

Vinorelbine is a third-generation vinca alkaloid. It is used as a chemotherapy medication to treat several types of cancers, such as breast cancer and non-small cell lung cancer. Vinorelbine disrupts the normal function of microtubules and stops cell division.
Vinorelbine was created by Pierre Potier at the CNRS in France in the 80s. The Vinorelbine drug was approved in France in 1989 and 1994 by the FDA. In 2003, the US agreed on marketing generics for Vinorelbine.
Vinorelbine medicine is on the World Health Organization's List of Essential Medicines. In most European countries, the use of Vinorelbine is allowed to treat non-small cell lung cancer and breast cancer. In the United States, it is approved only for non-small cell lung cancer.

Vinorelbine manufacturers and wholesalers:

Vinorelbine has several brand names. Vinorelbine medicine is known as Navelbine in the US and France. The first Vinorelbine manufacturer was Pierre Fabre Medicament. But now, the Vinorelbine medicine has many manufacturers such as Actavis Totowa Llc, App Pharmaceuticals Llc, Baxter Healthcare Corp Anesthesia and Critical Care, Bedford Laboratories, Ebewe Pharma, Hospira Inc, Teva Parenteral Medicines Inc.
Vinorelbine suppliers market it in the form of an oral solution or solution for injection. For the intravenous solution, Vinorelbine is available in 10 mg/mL and 50 mg/5 mL for Generics and Navelbine.

Vinorelbine for sales:

For 1 milliliter of Vinorelbine in the US, it costs from $24.62 to $30.50 and for 5 milliliters Vinorelbine costs from $17.02 to $85.10. Under the name Navelbine, one 50 mg/5 ml vial costs from $27.6 to $42.0.
As Vinorelbine is available globally, fraudulent online pharmacies may attempt to sell an illegal generic version of Vinorelbine. Thanks to Pipelinepharma online marketplace, you can be sure of the qualifications of the Vinorelbine sellers because they all have been through quality control procedures. Plus, being sure your future partner is qualified, you will save time sourcing for the product and buyer or seller, because it is all in one safe place: Pipelinepharma B2B marketplace. On the platform, you can easily place orders for any pharmaceutical products, including Vinorelbine. From our online marketplace, Vinorelbine is mostly available from Argentina, China, India, and Taiwan.

How to use Vinorelbine drugs?

To treat breast cancer, an adult should take IV: 25 mg/m2 every seven days. It is highly recommended for pregnant women not to take the Vinorelbine drug.
Taking Vinorelbine can cause some side effects such as bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, soreness, stinging, swelling, tenderness, blood in the urine.
Vinorelbine vials should be stored at 2°C to 8°C and not be frozen.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible